Výsledky vyhledávání - "Miheer Pujara"

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer

Autor: Paul A. Bunn, D. Ross Camidge, Robert C. Doebele, Erin L. Schenk, Rao Mushtaq, Dara L. Aisner, Kurtis D. Davies, Jose M. Pacheco, Sydney Marsh, Tejas Patil, William T. Purcell, Miheer Pujara, Christine Azelby

Publikováno v: Clin Lung Cancer

The outcomes for atypical EGFR and HER2 alterations remain underexplored. We performed a single-center retrospective study to determine unique clinical characteristics, treatment outcomes, and resistance mutations among this subgroup. Patients with a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328f57c3dbd54d30462f37762aadafe4
https://pubmed.ncbi.nlm.nih.gov/31859066

Zobrazit plný text záznamu

Clinicopathologic profile and treatment outcomes of non-sensitizing EGFR and HER2 (ERBB2) activating mutations in NSCLC: Results from a single-center retrospective study

Autor: William T. Purcell, Erin L. Schenk, Sydney Marsh, Robert C. Doebele, Tejas Patil, Rao Mushtaq, Miheer Pujara, Paul A. Bunn, Dara L. Aisner, Jose Maria Pacheco, Christine Azelby, D. Ross Camidge

Publikováno v: Journal of Clinical Oncology. 37:9090-9090

9090 Background: The clinicopathologic characteristics and optimal treatment strategies for non-sensitizing EGFR ( ns- EGFR) and HER2 activating mutations in NSCLC remain unclear. Methods: Single-center retrospective study of patients seen at Univers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::378dd013ba8d1eb07ced2144826a4103
https://doi.org/10.1200/jco.2019.37.15_suppl.9090

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání